These two research groups independently identified a novel subtype of ALL that lacked the Philadelphia chromosome (BCR::ABL1 fusion) but exhibited gene expression profiles similar to Philadelphia chromosome‐positive ALL (Ph+ ALL). Here, ABL1 is linked to acute lymphoblastic leukemia.